A Recipe for Delirium: Community-Acquired Pneumonia and Sickle Cell Anemia With Moyamoya Disease

Franklin Alier1, Lyanne Santana2, Waiz Wasey3

  • 1Psychiatry, Southern Illinois University School of Medicine, Springfield, USA.

Cureus
|November 30, 2022
PubMed

Insights

Moyamoya disease (MMD) is a rare cerebrovascular disorder causing brain artery obstruction. This case highlights MMD

Area of Science:

  • Neuroscience
  • Vascular Neurology
  • Genetics

Background:

  • Moyamoya disease (MMD) is a rare, progressive cerebrovascular disorder characterized by stenosis of the terminal internal carotid arteries and the development of abnormal collateral vessels.
  • MMD can affect individuals of various ethnicities worldwide, often presenting with stroke or transient ischemic attack symptoms.
  • Chronic cerebrovascular changes in MMD can lead to neurological and cognitive deficits.

Observation:

  • A young African American female with a history of sickle cell anemia (SCA) presented with community-acquired pneumonia (CAP).
  • The patient exhibited psychiatric symptoms including paranoia, delusional guilt, and mutism.
  • Undiagnosed Moyamoya disease was identified as a contributing factor to her presentation.

Findings:

  • The co-occurrence of Moyamoya disease and sickle cell anemia presents unique diagnostic and management challenges.
  • Cerebrovascular compromise in MMD can exacerbate neurological symptoms, including psychiatric manifestations.
  • Prompt diagnosis and management of MMD are crucial in patients with complex medical histories.

Implications:

  • This case underscores the importance of considering MMD in patients with unexplained neurological and psychiatric symptoms, particularly those with underlying conditions like SCA.
  • Early recognition and treatment of MMD can potentially prevent severe neurological sequelae.
  • Further research is needed to elucidate the interplay between MMD, SCA, and psychiatric comorbidities.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
423
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
352
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K